Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Wassil Jim, holds the title of CHIEF OPERATING OFFICER at Vaxcyte, Inc..
On 2026-06-01, the insider transacted 2,250 shares.The shares were transacted at a weighted average price of $49.52 per share, resulting in a total market-relevant value of $111K.
**Transaction:** sell of 2,250 shares by Wassil Jim (CHIEF OPERATING OFFICER). **Strategic Implications (Investor Edge):** The sale is small relative to the insider's total holdings and is likely for personal financial planning or tax purposes. Without evidence of a 10b5-1 plan or open market purchase, this transaction does not provide a strong signal for investors to adjust positions. **Key Takeaways:** - COO sold a small portion of holdings (1.4% of post-sale shares), not a significant liquidation. - Transaction is routine and likely for personal liquidity, not a bearish indicator. - No open market purchase or large-scale sell-off to suggest insider conviction change.
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.